| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |